Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 08, 2025 08:30 ET | Source: Stemline Therapeutics, Inc.

Menarini Group Presents Elacestrant (ORSERDU®) Phase 2 Combination Data in Patients with ER+, HER2- Metastatic Breast Cancer (mBC) at the 2025 San Antonio Breast Cancer Symposium

In addition, the expansive elacestrant clinical development program updates reinforce its potential as a backbone endocrine therapy in combination settings, as well as in both metastatic and early...
November 24, 2025 08:30 ET | Source: Stemline Therapeutics, Inc.

Menarini Group Announces New Data on ELZONRIS® (tagraxofusp-erzs) to be Presented at the 67th American Society of Hematology Annual Meeting and Exposition

Data spans five abstracts including two oral presentations with important findings for patients living with blastic plasmacytoid dendritic cell neoplasm (BPDCN).BPDCN is a highly aggressive, orphan...
January 10, 2025 09:00 ET | Source: Stemline Therapeutics, Inc.

Menarini Group and Insilico Medicine Enter a Second Exclusive Global License Agreement for an AI Discovered Preclinical Asset Targeting High Unmet Needs in Oncology

This is the second asset Menarini Group has inlicensed from Insilico Medicine which was discovered through their generative AI platform, similar to the preclinical stage KAT6 inhibitor (MEN2312)...
October 19, 2023 10:04 ET | Source: Menarini

Paralympic Basketball: a new season begins for Volpi Rosse Menarini

FLORENCE, Italy, Oct. 19, 2023 (GLOBE NEWSWIRE) -- Heart, passion, and the determination to overcome challenges. The Volpi Rosse Menarini are once again setting their sights on the hoop as they make...